AC
SBFMW

Armistice Capital’s Sunshine Biopharma Inc Warrant SBFMW Stock Holding History

Armistice Capital’s Portfolio SBFMW Stock Details SBFMW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-884,600
Closed -$876K – 199
2022
Q1 		$876K Buy
+884,600
New +$617K 0.02% 111

Other funds holding SBFMW

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM

Armistice Capital's SBFMW Position: Q2 2022 in Review

Armistice Capital sold out of Sunshine Biopharma Inc Warrant (SBFMW) in Q2 2022, closing a stake of 884,600 shares — an estimated $876K sold.

Armistice Capital first reported a position in SBFMW in Q1 2022 and held it in 1 quarter. The position peaked at $876K in Q1 2022. 4 funds tracked by Wall St. Rank hold SBFMW as of Q2 2022.

  • Armistice Capital reported no remaining Sunshine Biopharma Inc Warrant position as of Q2 2022 after selling out during the quarter.
  • Armistice Capital sold 884,600 Sunshine Biopharma Inc Warrant shares in Q2 2022, an estimated $876K.
  • Armistice Capital first reported a position in Sunshine Biopharma Inc Warrant in Q1 2022 and held it in 1 quarter.
  • Armistice Capital's Sunshine Biopharma Inc Warrant position peaked at $876K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Sunshine Biopharma Inc Warrant as of Q2 2022.

Based on Armistice Capital's 13F filing for Q2 2022, filed 15 Aug 2022.